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Abstract 
The adaptive immune system recognizes antigens via an immense array of antigen-binding 
antibodies and T-cell receptors, the immune repertoire. The interrogation of immune 
repertoires is of high relevance for understanding the adaptive immune response in disease 
and infection (e.g., autoimmunity, cancer, HIV). Adaptive immune receptor repertoire 
sequencing (AIRR-seq) has driven the quantitative and molecular-level profiling of immune 
repertoires thereby revealing the high-dimensional complexity of the immune receptor 
sequence landscape. Several methods for the computational and statistical analysis of large-
scale AIRR-seq data have been developed to resolve immune repertoire complexity in order 
to understand the dynamics of adaptive immunity. Here, we review the current research on (i) 
diversity, (ii) clustering and network, (iii) phylogenetic and (iv) machine learning methods 
applied to dissect, quantify and compare the architecture, evolution, and specificity of 
immune repertoires. We summarize outstanding questions in computational immunology and 
propose future directions for systems immunology towards coupling AIRR-seq with the 
computational discovery of immunotherapeutics, vaccines, and immunodiagnostics. 
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Introduction 
 
The adaptive immune system is responsible for the specific recognition and elimination of antigens 
originating from infection and disease. Molecular recognition of antigens is achieved through the 
vast diversity of antibody (B-cell receptor, BCR) and T-cell receptors (TCR). The genetic diversity 
of these adaptive immune receptors is generated through a somatic recombination process that acts 
on their constituent V, D, and J segments (1,2). During the gene rearrangement process, additional 
sequence diversity is created by nucleotide deletion and addition, resulting in a potential diversity 
of >1013 unique B- and T-cell immune receptor sequences (3–6). The adaptive immune repertoire 
often refers to the collection of all antibody and T-cell immune receptors within an individual, and 
represents both the ongoing and past immune status of an individual. Current threats, for example 
of pathogenic nature, are countered by B- and T-cell clonal expansion and selection (7), whereas 
past ones are archived in immunological memory compartments (8). Immune repertoires are highly 
dynamic. They are constantly evolving within the repertoire sequence space, which is defined as 
the set of all biologically achievable immune receptor sequences. Repertoire dynamics and 
evolution span several orders of magnitude in size (germline gene to clonal diversity), physical 
components (molecular to cellular dynamics) and time (short-lived responses to immunological 
memory that can persist for decades (9–14)).  
The quantitative resolution of immune repertoires has been fueled by the advent of high-throughput 
sequencing (2,15–20). Since 2009, high-throughput adaptive immune receptor repertoire 
sequencing (AIRR-seq) has provided unprecedented molecular insight into the complexity of 
adaptive immunity by generating datasets of 100 millions to billions of reads (6,21,22). The 
exponential rise in immune repertoire data has correspondingly led to a large increase in the 
number of computational methods directed at dissecting repertoire complexity (Figures 1,2) (23). 
Immune repertoire sequencing has catalyzed the field of computational and systems immunology in 
the same way that genomics and transcriptomics has for systems and computational biology (23). 
To date, the computational methods that have been developed and applied to immune repertoires 
relate to (i) the underlying mechanisms of diversity generation, (ii) repertoire architecture, (iii) 
antibody evolution, and (iv) molecular convergence. 
This review provides an overview of the computational methods that are currently being used to 
dissect the high-dimensional complexity of immune repertoires. We will treat only those methods 
that are down-stream of data preprocessing (although currently there is no consensus on standard 
operating pre-processing procedures, please refer to recent reviews on these subjects (2,17,24)). 
Specifically, this review centers on computational, mathematical and statistical approaches used to 
analyze, measure and predict immune repertoire complexity. The description of these methods will 
be embedded within the main areas of immune repertoire research. Given that the genetic structure 
of antibody and T-cell receptors is very similar, the majority of the methods illustrated in this 
review can be applied both in the context of antibody and T-cell studies. Exceptions to this rule are 
clearly stated. 
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Measuring immune repertoire diversity 
 
The immense diversity is one of the key features of immune repertoires and enables broad antigen 
recognition breadth (Figure 1A, 2A). The maximum theoretical amino acid diversity of immune 
repertoires is ≈10140 (calculated as 20110*2). The calculation takes into account the 20 unique amino 
acids, the 110 amino acids long variable region of immune receptors, and the 2 variable regions 
composing each receptor (IGVL-IGVH or TCRVa-TCRVb) (25). This enormous diversity, 
however, is restricted in humans and mice by a starting set of V, D, J gene segments leading to a 
potential diversity of about 1013–1018 (3–6,26–30). Only a fraction of the potential diversity is 
represented at any point in time in any given individual: the number of B and T cells is restricted 
(human: 1011–12) and the number of different clones, depending on clone definitions, reaches about 
109 in humans and 106–7 in mice (3,5,6,31). The study of immune repertoire diversity ranges from 
the study of (i) the diversity of the building blocks of immune repertoires (V, D, J segments) and 
antibody lineage reconstruction (ii) to the mathematical modeling of VDJ recombination (iii) to the 
estimation of the theoretical and biologically available repertoire frequency diversity (32). 
Together, these subfields of repertoire diversity analysis have expanded our analytical and 
quantitative insight into the creation of naïve and antigen-driven antigen receptor diversity. 
Accurate quantification of repertoire diversity relies first and foremost on the correct annotation of 
sequencing reads. Read annotation encompasses multiple steps: (i) calling of V, D, J segments, (ii) 
subdivision into framework (FR) and complementarity determining regions (CDR), (iii) 
identification of inserted and deleted nucleotides in the junction region, (iv) the quantification of 
the extent of somatic hypermutation (for antibodies). VDJ annotation tools were recently reviewed 
by Greiff et al. and Yaari et al. (17,24). An updated version is currently maintained on the B-T.CR 
forum (http://b-t.cr/t/list-of-v-d-j-annotation-software/18). The B-T.CR forum is an AIRR-seq 
community platform for community-edited Wiki pages related to datasets and analysis tools as well 
as scientific exchange on current relevant topics in AIRR-seq (33,34).  
Accurate antigen receptor germline gene genotyping is crucial for predicting adaptive immunity 
(personalized and precision medicine) in the genetically diverse human population (30,35). All 
VDJ annotation tools rely, at least partly, on a reference database of germline gene alleles. A 
reference database that is not identical to that of the individual from which the sequencing data is 
being annotated bears the potential of inaccurate annotation. This could affect for example the 
accuracy of the calling of V, D, and J genes and alleles as well as the quantification of somatic 
hypermutation. Antibody gene allele variation has also been linked to differential effectiveness of 
the humoral immune response (30,35). Indeed, an increasing number of human germline gene 
alleles – representing one or several single nucleotide polymorphisms – has been recently detected 
(30,36–39). These discoveries call into question the widely adopted practice of using one central 
germline reference database containing a more or less static set of non-personalized germline gene 
alleles. To address this problem, Corcoran et al. developed a software package (IgDiscover), which 
employs a cluster identification approach to reconstruct de novo from an AIRR-seq dataset the 
corresponding V-gene germline database – all without a priori knowledge of existing germline 
gene databases (40). By doing so, they detected extensive individual germline gene differences 
among rhesus macaques (40). Complementarily, Gadala-Maria et al. developed TiGER (Tool for Ig 
Genotype Elucidation via Rep-Seq), which detects novel alleles based on mutation pattern analysis 
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(37). In contrast to IgDiscover, TiGER uses initial VDJ allele assignments with existing databases 
and software. Extending the analysis of germline gene diversity to the population level, Yu et al. 
built Lym1K, which is a database that combines validated alleles with novel alleles found in the 
1000 Genomes Project (41,42). In addition to database-centered approaches, probabilistic 
annotation enabled the detection of novel IgV-genes and led to the discovery that substitution and 
mutation processes are (although reproducible across individuals) segment and allele-dependent, 
thus further refining VDJ annotation and downstream diversity measurement (4,43–46).  
As a direct application in fundamental immunology, the advent of AIRR-seq has enabled the 
opportunity to quantitatively test whether VDJ recombination is a random process. The ability to 
generate large datasets allowed several studies to show evidence of biases in VDJ recombination, 
as some germline gene frequencies (and combinations thereof) were found to occur more often than 
others (6,21,47–49). In order to mathematically model the process of VDJ recombination in both T 
and B cells, Elhanati et al. and Murugan et al. have employed techniques borrowed from statistical 
physics (maximum entropy, Hidden Markov and probabilistic models) (4,5,44) to uncover the 
amount of diversity information inherent to each part of antibody and TCR sequences (entropy 
decomposition). VDJ recombination probability inference was mostly performed on non-
productive sequences (e.g., out-of-frame, containing stop codon) as these receptors were assumed 
to be exempt from selection, thus representing unselected products of the generation process (4).  
The deep sequence coverage of AIRR-seq has also led to the discovery of public clones or 
clonotypes – sequences that are shared across two or more individuals (6,50–52). The existence of 
naïve and antigen-associated public clones signifies a predetermined reduction in a priori genetic 
and antigen-driven immune receptor diversity (6).	Although the exact definition of what constitutes 
a “public clone” is debatable (53), advancements have been made in understanding the generation 
and structure of public B- and T-cell clonotypes. By quantifying VDJ recombination probabilities 
as described above, Elhanati et al. have suggested that the emergence of public clonotypes is a 
direct consequence of the underlying VDJ recombination bias (54). The inference of VDJ 
recombination statistics of naïve B- and T-cell populations may be of use in vaccination studies for 
helping distinguish public antigen-specific clonotypes from genetically (naïve) predetermined ones. 
If feasible, such an approach might render the need of a healthy control cohort for determining 
naïve public clones superfluous (46,55). Complementarily, Greiff et al. have demonstrated 
extensive VDJ recombination bias by support vector machine analysis. Specifically, it showed that 
both public and private clones possess predetermined sequence signatures independent of mouse 
strain, species and immune receptor type (antibody, TCR).  These sequence signatures were found 
in both naïve and antigen-selected B-cell compartments, which might suggest that naïve 
recombination bias exerts a stronger diversity-constricting effect than antigen-driven evolution 
(56). 	
While the above-described methods of immune repertoire diversity analysis are relatively new, the 
quantification and comparison of clonotype diversity has been already studied in the era preceding 
high-throughput sequencing platforms by borrowing and adapting from mathematical ecology (57–
60). The first step to quantifying clonal repertoire diversity is the definition of clonotype. 
Definitions of clonotype used in the literature range from the exact amino acid CDR3 to clusters of 
(e.g., CDR3) sequences to the sequence of entire variable chain regions (IGVL-IGVH or TCRVa-
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TCRVb) using methods ranging from likelihood-based lineage inference to distance-based 
measures. A complete list of clonotyping tools has been compiled on the B-T.CR forum (http://b-
t.cr/t/list-of-b-cell-clonal-identification-software/22). The debate on what constitutes a clonotype is 
ongoing and beyond the scope of this review. The interested reader is kindly referred to two 
extensive reviews (17,61) and a recent report by Nouri and Kleinstein, who have developed a 
flexible user-defined method for clonotype identification (62). 
To measure clonotype diversity, diversity indices are used (detailed reviews on diversity indices 
have been recently published (17,24)). Briefly, diversity indices enable the comparison of 
repertoire diversity by parameterizing the repertoire space. They thus overcome the problem of 
mostly clonally distinct repertoires (63). Several dedicated software packages exist for diversity 
index calculations (64–67). Briefly, the Diversity ( !" ) of a repertoire of S clones is usually 
calculated as follows: 	 !" = %&"'&() **+,  (Hill-Diversity), where fi is the frequency of the ith 
clone weighted by the parameter -. Special cases of this Diversity function correspond to popular 
diversity indices in the immune repertoire field: species richness (- = 0), and the exponential 
Shannon-Weiner (- → 1), inverse Simpson (- = 2), and Berger-Parker index (- → ∞). The higher 
the value of alpha, the higher becomes the influence of the more abundant clones on the !" . Due 
to the mathematical properties of the Diversity function (Schur concavity, (68)), different 
repertoires may yield qualitatively different !"  values depending on the Diversity index used 
(Figure 1 in Greiff et al., (63)). Thus, for any discriminatory diversity comparisons, at least two 
Diversity indices should be considered. Diversity profiles, which are collections (vectors) of 
several Diversity indices,  have been suggested to be superior to single diversity indices, when 
comparing clonal diversity (63,64,69). Using hierarchical clustering, - -parametrized diversity 
profiles have been shown to faithfully capture the shape of a repertoire’s underlying clonal 
frequency distribution, which represents the state of clonal expansion (63). Thus, diversity profiles 
can serve as a parameterized proxy for a repertoire’s state of clonal expansion. Additionally, Mora 
and Walczak showed that the Rényi entropy (the mathematical foundation of Hill-Diversity 
profiles) can be constructed, in some cases, from rank-frequency plots (70) thereby establishing a 
direct mathematical link between clonal frequency distribution and diversity indices. Another 
interesting novel diversity analysis method is the clonal plane and the polyclonal monoclonal 
diversity index developed by Afzal et al. (71). Briefly, these two related concepts represent 
repertoire diversity in a coordinate system spanned by species richness and evenness. This allows a 
visually straightforward identification of polyclonal and oligoclonal samples. 
Although clonal frequency distributions can, in most cases, not be compared directly across 
individuals due to restricted clonal overlap, their mathematical description has been the object of 
several studies. Specifically, clonal frequency distributions were found to be power-law distributed, 
with a few abundant clones, and a large number of lowly abundant clones (63,72–74). Furthermore, 
Schwab et al. showed analytically and via numerical simulations that Zipf-like distributions, a 
subclass of power-law distributions, arise naturally if fluctuating unobserved variables affect the 
system (e.g., a variable external antigen environment influencing the observed antibody repertoire) 
(75). Indeed,  it could be shown that clonotype diversity (or state of clonal expansion) contains 
antigen-associated information on the host immune status (6,63,76).  
In order to compare differences between diversity profiles, one should also consider resampling 
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strategies as implemented the R package Change-O by Gupta et al. These allow the determination 
of confidence areas around each diversity profile (64,77) in the presence of differently sized 
repertoires. The precision of diversity calculation in case of incomplete sampling is of special 
importance when gaining information on human repertoires, which often are restricted to the 
isolation of a limited number of B and T cells from peripheral blood (17,78–80).  
Although the quantification of diversity is one of the more mature subfields of computational 
repertoire immunology, numerous open questions remain: (i) Diversity has been measured from 
many different perspectives (germline gene diversity, state of clonal expansion, clonal size), thus 
capturing different dimensions of the repertoire diversity space. Is it possible to devise a universal 
metric that synthetizing different aspects of immune repertoire diversity into one? Such a metric 
would be very useful for repertoire-based immunodiagnostics. (ii) Hidden Markov and Bayesian 
(probabilistic) approaches have been used for modeling VDJ recombination. Those approaches, 
however, capture only short-range sequence interactions. Might, therefore, recurrent neural 
network approaches be more appropriate to model the immune repertoire sequence space given 
their ability to account for sequence interactions of arbitrary length (81,82)? (iii) Finally, we still 
have only very superficial insight into the biological diversity of antigen-specific repertoires and 
the combination rules of IGVL/IGVH and TCRVa/TCRVb chains due to the lack of large-scale data 
(74,83–86). Once more extensive data has become available, can we leverage machine learning to 
uncover the underlying structure of antigen-specific repertoires and the prediction rules of chain 
pairing? Uncovering these immunological prediction rules is crucial for the knowledge-based 
development of antibody and T-cell based immunotherapeutics.  
 
Resolving the sequence similarity architecture of immune repertoires 
 
The entirety of similarity relations among immune receptor sequences is called the similarity 
architecture of an immune repertoire. Thus, unlike immune repertoire diversity which is based on 
the frequency profiles of immune clones, sequence similarity architecture captures frequency-
independent clonal sequence similarity relations. The similarity among immune receptors directly 
influences antigen recognition breadth: the more dissimilar receptors are, the larger is the antigen 
space covered.  Given the genetic, cellular and clonal restrictions of immune repertoire diversity, 
the similarity architecture of antibody and T-cell repertoires has been a longstanding question and 
has only recently begun to be resolved. Understanding the sequence architecture of immune 
repertoires is, for example, crucial in the context of antibody therapeutics discovery for the 
conception of naïve antibody libraries and  synthetic repertoires that recapitulate natural repertoires 
(87).  
One powerful approach to interrogate and measure immune repertoire architecture is network 
analysis (Figure 1B, 2B) (87–93). Networks allow interrogation of sequence similarity and thereby 
add a complementary layer of information to repertoire diversity analysis. Clonal networks are built 
by defining each clone (nucleotide or amino acid sequence) as a node (Figure 1B). An edge 
between clones is drawn if they satisfy a certain similarity condition, which is predefined via a 
string distance (e.g., Levenshtein distance, LD) resulting in undirected Boolean networks (87–
90,92,93). The default distance is usually 1 nucleotide or 1 amino acid difference but larger 
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distances have also been explored (87). Thus, the construction of clonal networks requires the 
calculation of an all-by-all distance matrix. While the complete distance matrix can be computed on 
a single machine with repertoires of clone sizes <10,000, it becomes computationally expensive in 
terms of time and memory to calculate networks of clone sizes that exceed 105 clones – which is the 
size of many repertoires in both mice and humans (3,5,6). Therefore, Miho et al. have developed a 
high-performance computing pipeline (imNet), which can compute distance matrices and construct 
corresponding large-scale repertoire networks (87). This method led to the biological insight that 
antibody repertoire networks are, in contrast to other systems (94,95), resistant to subsampling, 
which is of great importance for the network analysis of human repertoires where limited access to 
B-cell populations and lymphoid organs restricts complete biological sampling (17,79). Although 
networks of a few thousand nodes may be visualized using software suites such as igraph (96), 
networkx (97), gephi (98) and cytoscape (99), interpretation of the visual graphics is not 
informative for networks beyond a clonal size of 103 (87). Furthermore, visualization of networks 
provides only marginal quantitation of the network similarity architecture thus limiting the 
quantitative understanding of immune repertoires. Graph properties and network analysis have 
been recently employed in order to quantify the network architecture of immune repertoires 
(87,93). Architecture analytics may be subdivided into properties that capture the repertoire at the 
global level (generally one coefficient per network), and those that describe the repertoire at the 
clonal and thus local level (one coefficient per clone per repertoire, vector of size equal to the clone 
size) (87).  
Global coefficients are for example degree distribution, clustering coefficient, diameter and 
assortativity (87). The degree of a node is the number of its edges (i.e., the number of similar 
clones to a certain clone) and a repertoire’s degree distribution quantifies the abundance of node 
degrees (i.e., clonal similarities) across clones of a repertoire. This degree distribution has been 
used to describe and classify networks by type, such as power-law (a few highly connected clones 
and many clones with few connections), which is reminiscent of antigen-driven clonal expansion, 
or exponential (more even degree distribution across clones, which cover an extensive sequence 
space) is more reflective of naïve repertoires (87). The degree distribution thus provides insights 
into the overall distribution of connectedness (clonal similarities) within a repertoire and its state of 
clonal sequence expansion. Local characterization allows for the interrogation and correlation of 
additional clonal related features, such as frequency and antigen specificity, within the immune 
repertoire architecture. Local parameters are for example: degree, authority, closeness, betweenness 
and PageRank (87). PageRank, for instance, measures the importance of the similarity between two 
CDR3 clones within the network. Detailed mathematical descriptions of available network 
parameters have been described elsewhere (87,100,101). 
Complementary to networks, similarity indices have been devised that provide a continuous 
description of repertoire architecture by quantifying the similarity between all sequences of a 
repertoire (using distance metrics) on a scale ranging from 0 (zero similarity) to 100% (all 
sequences are 100% identical) (6,102). In addition to sequence similarity, the index by Strauli and 
Hernandez takes the frequency of each sequence into account thus normalizing sequencing 
similarity by the frequency of each of the pairwise compared sequences (102). 
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The assessment of repertoire architecture has only recently started to transition from the visual 
investigation of clusters of immune receptor sequences to the construction of large-scale networks 
and truly quantitative analysis of entire repertoires across similarity layers (> 1 amino 
acid/nucleotide differences). This advance enabled the discovery of fundamental properties of 
repertoire architecture such as reproducibility, robustness and redundancy (87). And although the 
biological interpretation of the mathematical characterization of immune repertoire networks is at 
an early stage, the universal use of network analysis in the deconvolution of complex systems 
(100,101) suggests a great potential in immune repertoire research. Many important questions 
remain: (i) How can network repertoire architecture be compared across individuals without 
condensing networks into network indices without potentially losing information? Thus, can 
discrete and continuous representation of repertoire architecture be merged into one comprehensive 
mathematical framework? (ii) Can the linking of networks across similarity layers serve to 
understand the dynamic and potential space of antigen-driven repertoire evolution (87)? (iii) Is the 
network structure that is observed on the antibody immunogenomic level, also maintained on the 
phenotypic and immunoproteomics level of serum antibodies (103–109)? 
 
Retracing the antigen-driven evolution of antibody repertoires  
 
Upon antigen challenge, B cells expand and hypermutate their antibody variable regions, thus 
forming a B-cell lineage that extends from the naïve unmutated B cells, to somatically 
hypermutated memory B cells (25), to terminally-differentiated plasma cells (11). Somatic 
hypermutation is unique to B cells and absent in T cells. Retracing antibody repertoire evolution 
enables insights into how vaccines (76) and pathogens shape the humoral immune response (110–
112).  
In order to infer the ancestral evolutionary relationships among individual B cells, lineage trees 
are constructed from the set of sequences belonging to a clonal lineage (Figure 1C, 2C). A clonal 
lineage is defined as the number of receptor sequences originating from the same recombination 
event. For building a lineage tree, a common preprocessing step is to group together all sequences 
with identical V, J gene and CDR3 length. Schramm et al. published a software for the 
ontogenetic analysis of antibody repertoires, which is designed to enable the automation of 
antibody repertoire lineage analysis. Importantly, it provides interfaces to phylogenetic inference 
programs such as BEAST and DNAML (113).  
In antibody repertoire phylogenetics, there is no consensus as to which phylogenetic method is 
optimal for the inference of lineage evolution (17,114). Most of the current phylogenetic methods 
rely on assumptions that may be true for species evolution but might be invalid for antibody 
evolution. One prominent example is the assumption that each site mutates independently of the 
neighboring nucleotides, which is not the case in antibody evolution (114). Additionally, 
antibodies evolve on time scales that differ by several orders of magnitudes from those of species. 
These two factors likely decrease the accuracy of clade prediction (clade: set of descendent 
sequences that all share a common ancestor), thus potentially impacting antibody phylogenetic 
studies. 
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Several phylogenetic methods, such as Levenshtein distance (LD), neighbor-joining (NJ), 
maximum parsimony (MP), maximum-likelihood (ML), and Bayesian inference (BEAST) have 
been used for delineating the evolution of B-cell clonal lineages from antibody repertoire 
sequencing data (77,115–117). For general information regarding the methods, refer to the review 
by Yang and Rannala (118). Briefly, both LD and NJ are distance-based methods that rely upon 
an initial all-by-all distance matrix calculation and have been implemented in many computational 
platforms (Clustal, T-REX) and R packages (ape, phangorn) (119–122). Even in the event >105 
sequences per sample, the distance matrix calculation in phylogenetics poses less of a problem 
than in network analysis since a sample’s sequences are grouped by lineage members of identical 
V-J gene and CDR3 length thus reducing computational complexity. The relatively short 
computation-time of distance-based methods, renders them particularly useful for initial data 
exploration (118). Maximum parsimony attempts to explain the molecular evolution by non-
parametrically selecting the shortest possible tree that explains the data (24). Maximum 
parsimony trees can be produced using several available tools (e.g., PAUP, TNT, PHYLIP, 
Rphylip) (123–126). Both ML and BEAST infer lineage evolution using probabilistic methods, 
which can incorporate biologically relevant parameters such as transition/transversion rate and 
nucleotide frequencies. A variety of ML tools have been developed (e.g., PhyML, RAxML, and 
MEGA) (127–129). While multiple phylogenetic tools utilizing Bayesian methods exist 
(130,131), this review focuses on  BEAST given its recurrent use in antibody repertoire studies 
(113,117,132–134). BEAST traditionally employs a Markov chain Monte Carlo (MCMC) 
algorithm to explore the tree parameter space. This computationally expensive process limits the 
practical number of sequences per lineage tree to <103. Despite the extensive computational 
requirements (both in memory and in run time), BEAST has the advantage of producing time-
resolved phylogenies and inferring somatic hypermutation rates (131,132). The BEAST 
framework shows, therefore, the highest scientific benefit when applied to experiments examining 
antibody evolution within the same host across multiple sampling time points (117), as inferred 
mutation rates and tree heights (duration of evolution) are reported in calendar time.  
Yermanos et al. have compared five of the most common phylogenetics reconstruction methods 
for antibody repertoire analysis in terms of their absolute accuracy and their concordance in clade 
assignment using both experimental and simulated antibody sequence data (132). Correctly 
inferring the clades of a phylogenetic tree is crucial for describing the evolutionary relationship 
between clonally selected and expanded B-cells (i.e., memory B cells) that belong to a given 
lineage (i.e., derived from a naïve B cell). Phylogenetic trees inferred by the methods tested (LD, 
NJ, ML, MP, BEAST) resulted in different topologies as measured by both clade overlap (number 
of internal nodes sharing the same descendant sequences) and treescape metric (comparison of the 
placement of the most recent common ancestor of each pair of tips in two trees) (135). These 
results suggest caution in the interpretation and comparison of results from the  phylogenetic 
reconstruction of antibody repertoire evolution (132).  
The accurate reconstruction of antibody phylogenetic trees is tightly linked to the detailed 
understanding of the physical and temporal dynamics of somatic hypermutation along antigen-
driven antibody sequence evolution. Mutation statistics can be inferred probabilistically  to 
account for the fact that the likelihood of mutation is not uniformly distributed over the antibody 
VDJ region (45,46). For example, there is a preference to mutate particular DNA motifs called 
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hotspots (length: 2–7bp) and concentrated in the CDRs over others (coldspots) (4,114,136,137). 
To uncover the sequence-based rules of somatic hypermutation targeting, Yaari et al. developed 
S5F, an antibody-specific mutation model. This model provides an estimation of the mutability 
and mutation preference for each nucleotide in the VDJ region of the heavy chain based on the 
four surrounding nucleotides (two on either side). The estimated profiles could explain almost 
half of the variance in observed mutation patterns and were highly conserved across individuals 
(114).  Cui et al. have, in addition, reported two new models that add to the heavy chain S5F 
model: the light chain mouse RS5NF and the light chain human S5F L chain model (138). 
Additionally, Sheng et al. investigated the intrinsic mutation frequency and substitution bias of 
somatic hypermutations at the amino acid level by developing a method for generating gene-
specific substitution profiles (139). This method revealed gene-specific substitution profiles that 
are unique to each human V-gene and also highly consistent between human individuals.  
The existence of hotspot and coldspot mutation motifs violates the standard assumption of 
likelihood-based phylogenetics, which is that evolutionary changes at different nucleotide or 
codon-sites are statistically independent. Furthermore, since hotspot motifs are, by definition, 
more mutable than non-hotspot motifs, their frequency within the B-cell lineage may decrease 
over time as they are replaced with more stable motifs (140). In order to explicitly parameterize 
the effect of biased mutation within a phylogenetic substitution model, Hoehn et al. developed a 
model that can partially account for the effect of context-dependent mutability of hot- and 
coldspot motifs, and explicitly model descent from a known germline sequence (141). The 
resulting model showed a substantially better fit to three well-characterized lineages of HIV-
neutralizing antibodies, thus being potentially useful for analyzing the temporal dynamics of 
antibody mutability in the context of chronic infection. In addition, Vieira et al. assessed the 
evidence for consistent changes in mutability during the evolution of B-cell lineages (133). Using 
Bayesian phylogenetic modeling, they showed that mutability losses were about 60% more 
frequent than gains (in both CDRs and FRs) in anti-HIV antibody sequences (133).  
Although computational methods tailored to the phylogenetic analysis of antibody evolution are 
slowly beginning to surface, many important problems remain. (i) First approaches in coupling 
clonal expansion information to the inference of phylogenetic trees have been developed (142). 
Will these additional layers of information enable a better prediction of antibody evolution? (ii) 
There has been progress in comparing the differences of antibody repertoires in the context of 
phylogenetic trees using the UniFrac distance measure (143,144). Briefly, for a given pair of 
samples, UniFrac measures the total branch length that is unique to each sample. The comparison 
of tree topologies, however, remains a challenge. This is because each lineage tree is composed of 
a different number of sequences and there are thousands, if not more, of simultaneously evolving 
lineages within a single host. Although methods exists for the comparison of unlabeled 
phylogenetic trees by, for instance, means of their Laplacian spectra (145), their application and 
ability to extract meaningful biological conclusions have not yet been realized. (iii) It is unclear to 
what extent antibody evolution differs between different acute and chronic viral infections, or 
different antigens. Specifically, is it possible to relate antigen-driven convergence and affinity 
(6,49,110) to phylogenetic antigen-specific signatures (146)? 
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Dissecting naïve and antigen-driven repertoire convergence  
 
Convergence (overlap) of immune repertoires describes the phenomenon of identical or similar 
immune receptor sequences shared by two or more individuals. Specifically, sequence 
convergence can either mean that (i) clones (public clonotypes, entire clonal sequence or 
clonotype cluster) or (ii) motifs (sequence substrings) are shared. Several researchers in the field 
have endeavored to quantify the extent of naïve and antigen-driven repertoire convergence using a 
large variety of computational approaches that quantify cross-individual  sequence similarity 
(6,52,76,110,147–149) (Figure 1D, 2D). Repertoire convergence may be of substantial 
importance for the prediction and manipulation of adaptive immunity (6).   
The simplest way to quantify sequence convergence is by clonotype overlap among pairwise 
samples expressed as a percentage normalized by the clonal size of either one or both of the 
samples compared (6,47,150). In case clonotypes are treated not as single sequences but clusters 
of sequences, clusters were defined as shared between samples if each sample contributed at least 
one sequence to the cluster (149). Overlap indices such as Morisita-Horn (151) add additional 
information to the measurement of clonal overlap by integrating the clonal frequency of compared 
clones (60,152,153). A parameterized version of the Morisita-Horn index, similarly to the Hill-
diversity, may be used to weigh certain clonal abundance ranges differently (58). Rubelt and 
Bolen expanded on the idea of an overlap index by incorporating both binned sequence features 
(e.g., clone sequences, germline genes) and their frequency for measuring the impact of heritable 
factors on VDJ recombination and thymic selection. Their Repertoire Dissimilarity Index (RDI) is 
a non-parametric Euclidian-distance-based bootstrapped subsampling approach, which enables 
the quantification of the average variation between repertoires (49,154). Importantly, it accounts 
for variance in sequencing depth between samples. Another clone-based approach was developed 
by Emerson et al. who mined public TCRβ clonotypes in CMV-positive and CVM-negative 
individuals in order to predict their CMV-status. To this end, they identified CMV-associated 
clonotypes by using Fisher’s exact test. Subsequently, these clonotypes were used within the 
context of a probabilistic classifier to predict an individual’s CMV-status. The classifier used 
dimensionality reduction and feature selection in order to mitigate the influence of the variance of 
HLA types across individuals (since the distribution of TCRβ clones is HLA-dependent) (147). 
Moving from the clonal to the subsequence-level, several groups compared the average distance 
between repertoires based on their entire sequence diversity (without predetermining feature 
bins). Specifically, Yokota et al. developed an algorithm for comparing the similarity of immune 
repertoires by projecting the high-dimensional inter-sequence relations, calculated from pairwise 
sequence alignments, onto a low-dimensional space (155). Such low-dimensional embedding of 
sequence similarity has the advantage of enabling the identification of those sequences that 
contribute most to inter-sample dis(similarity). As previously described, Strauli and Hernandez 
quantified sequence convergence between repertoires in response to influenza vaccination not 
only by incorporating genetic distance (Needleman-Wunsch algorithm) but also the frequency of 
each clonal sequence (102). Their approach relies on a statistical framework called functional data 
analysis (FDA), which is often used for gene-expression analysis. In their implementation, FDA 
models each sample as a continuous function over sampling time points and is thus suitable for 
the analysis of sequence convergence over a time-course experiment. The FDA framework has 
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the advantage of accounting for uneven time-point sampling and measurement error, both of 
which are common characteristics of immune repertoire datasets (2,17). Bürckert et al. also 
employed a method borrowed from gene expression analysis  (DESeq2) (156), to select for 
clusters of CDR3s, which are significantly overrepresented within different cohorts of immunized 
animals (157). These clusters exhibited convergent antigen-induced CDR3 signatures with 
stereotypic amino acid patterns seen in previously described tetanus toxoid and measles-specific 
CDR3 sequences.  
Given the high-dimensional complexity of the immune repertoire sequence space, sequence-
distance-based approaches might not suffice for covering the entire complexity of sequence 
convergence. A greater portion of the sequence space may be covered by sequence-based machine 
learning. Here the idea is that sequence signatures and motifs are shared between individuals 
belonging to a predefined class (e.g., different immune status). Sun et al. discriminated the TCRβ 
repertoire of mice immunized with and without ovalbumin  with 80% accuracy by deconstructing 
it into overlapping amino acid k-mers (158). Cinelli et al. used a one-dimensional Bayesian 
classifier for the selection of features, which were subsequently used for support-vector machine 
analysis (159). As a third machine-learning alternative, Greiff et al. leveraged gapped-k-mers and 
support vector machines for the classification of public and private clones with 80% accuracy 
from antibody and TCR repertoires of human and mice. This study used overlapping k-mers to 
construct sequence prediction profiles, which highlight those convergent sequence regions that 
contribute most to the identity of a class (public/private clones but also e.g., also different immune 
states and antigen specificities) (56). Beyond k-mers, several groups have exploited the addition 
of additional information such as physico-chemical properties (Atchley and Kidera factors), in 
order to provide more extensive information to machine-learning algorithms (160–164). Finally, a 
machine-learning independent approach using local-search graph theory for the detection of 
disease-associated k-mers was recently published by Apeltsin et al. (165). 
One of the longest-standing challenges in immunology is whether it is possible to predict antigen 
specificity from the sequence of the immune receptor (2,15,166–168). Sequence-dependent 
prediction implies that immune receptor sequences specific to one antigen share exclusive 
sequence signatures (motifs) or have higher intra-class than inter-class similarity (class = antigen). 
Two investigations in the direction of sequenced-based specificity prediction have recently been 
undertaken using sequence similarity (sequence distance) approaches (148,169). In one example, 
Dash et al. developed a distance measure, called TCRDist, which is guided by structural 
information on pMHC binding (148). Two TCRs sequences were compared by computing a 
similarity-weighted Hamming distance between CDR sequences, including an additional loop 
between CDR2 and CDR3. TCRDist was used to detect clusters of highly similar, antigen-
specific groups of TCRs that were shared across different mouse or human samples. In order to 
predict the antigen-specificity of a TCR, it was assigned to the cluster to which it had the highest 
similarity (as based on the TCRDist), resulting in highly accurate prediction (148). Using a 
similar approach, Glanville et al. developed GLIPH, a tool that identifies TCR specificity groups 
using a three-step procedure: (i) determining of shared motifs and global similarity, (ii) clustering 
based on local and global relationships between TCRs and (iii) analyzing the enrichment for 
common V-gene, CDR3 lengths, clonal expansion, shared HLA alleles in recipients, motif 
significance, and cluster size. This approach yielded also highly accurate prediction of antigen-
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specific TCRs and led to the design of synthetic TCRs (not existing in biological data) that 
retained antigen specificity (169).  
One of the biggest bottlenecks of learning the underlying principles of antigen-driven repertoire 
convergence is the scarcity of antigen-specific sequence data. This is not only a problem for 
machine learning but also network-based approaches, where one wishes to map antigen-specific 
information onto generated networks (87,93). To address this issue for T cells, Shugay et al. 
(VDJDB) and Tickotsky et al. (McPAS-TCR) have built dedicated and curated databases. VDJDB 
gathers >10,000 TCR sequences from different species associated with their epitope (>200) and 
MHC context (170). McPAS-TCR contains more than 5000 pathogen-associated TCRs from 
humans and mice (171). For antibodies, Martin et al. have conceived Abysis, which encompasses 
>5000 sequences of known function (from literature) from many species (>15) along with, where 
available, PDB 3D-structure information (172). 
Significant progress in the understanding of antigen-associated signatures has been made. 
However, several long-standing questions remain to be answered: (i) The emergence of antigen-
driven convergence and phylogenetic evolution are inherently linked. Is it feasible to model both 
phenomena in a unified computational environment similarly to recent efforts in coupling 
phylogenetics with the understanding of somatic hypermutation patterns (133,141)? (ii) Can 
recently developed models for the inference of VDJ recombination patterns and selection factors 
be applied to the analysis of antigen-associated sequence signatures (4,54)? (iii) Do more 
advanced sequence-based machine learning techniques such as deep neural networks, capable of 
capturing long-range sequence interactions (out of reach for k-mer-based approaches), improve 
modeling of the epitope and paratope space (82,173–178)?  
 
Conclusion  
 
The toolbox of computational immunology for the study of immune repertoires has reached an 
impressive richness leading to remarkable insights into B-and T-cell development (6,179), disease 
and infection profiling (76,77), propelling forward the fields of immunodiagnostics and 
immunotherapeutics (63,111,180). Here, we have discussed computational, mathematical and 
statistical methods in the light of underlying assumptions and limitations. Indeed, although 
considerably matured over the last few years, the field still faces several important and 
scientifically interesting problems: (i) There exist only few platforms to benchmark computational 
tools, thus hindering the standardization of methodologies. Recently, a consortium of scientists 
working in AIRR-seq has convened to establish and implement consensus protocols and 
simulation frameworks (http://airr.irmacs.sfu.ca/) (2,17,33,34,42). (ii) With the exponential 
increase of both bulk and single cell data (83,181), the scalability of computational tools is 
becoming progressively important. Although advances in this regard have been made in sequence 
annotation, clonotype clustering and network construction (62,87,182,183), further efforts 
especially in the field of phylogenetics are necessary to infer the evolution of large-scale antibody 
repertoires (132). (iii) Although there exist many approaches, which capture part of the immune 
repertoire complexity, a computational approach for the synthesis of many dimensions of the 
repertoire space at once is missing thus hindering a high-dimensional understanding of the 
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adaptive immune response. (iv) Very few attempts exist yet, which aim to link immune receptor 
and transcriptomics data (184,185). Recently, computational tools have been developed that can 
extract immune-receptor sequences from bulk and single-cell transcriptomic data (182,185–189). 
Linking immune repertoire and transcriptome may provide a deeper understanding of how 
antibody and T-cell specificity is regulated on the genetic level with profound implications for 
synthetic immunology (190–192). (v) Many methods capture a static space of repertoires and few 
methods create predictive quantitative knowledge. Increasing the predictive performance of 
computational methods will help in the antibody discovery from display libraries and 
immunizations, and the design of vaccines and immunodiagnostics (15,19,193–195).  
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Figure 1 The immune repertoire space is defined by diversity, architecture, evolution 
and convergence.  
(A) Diversity measurements are based on (i) the accurate annotation of V (D) J segments 
using deterministic and probabilistic approaches with population-level or individualized 
germline gene reference databases. (ii) Probabilistic and hidden Markov models allow 
inference of recombination statistics. (iii) Measurement of clonotype diversity using 
diversity profiles. 
 (B) Analysis of repertoire architecture relies predominantly on (i) clonal networks that are 
constructed by connecting nucleotide or amino acid sequence-nodes by similarity-edges. 
The sequence-similarity between clones is defined via a string distance (e.g., Levenshtein 
distance, LD) resulting in undirected Boolean networks for a given threshold 
(nucleotides/amino acids). An example of the global characterization of the network is the 
diameter, shown from the edges in black. An example of the local parameters of the 
network is the degree (n=1) related to the individual clonal node in black. (ii) Degree 
distribution is a global characteristic of immune repertoire networks, which can be used for 
analyzing clonal expansion. (iii) Several similarity layers decompose the immune repertoire 
along its similarity layers. Layer D1 captures clonal nodes similar by edit distance 1 (1 
nt./a.a. different) , D2 of distance 2 and so forth. 
(C) Assessing evolution of antibody lineages. (i) Reconstruction of phylogenetic trees. Stars 
indicate somatic hypermutation. (ii) Probabilistic methods for the inference of mutation 
statistics in antibody lineage evolution. (iii) Simulation of antibody repertoire evolution for 
benchmarking antibody-tailored phylogenetic inference algorithms. 
(D) Naïve and antigen-driven cross-individual sequence similarity and convergence in 
immune repertoires. (i) The Venn diagram shows sequences shared in the two repertoires 
(circles). Signature-like sequence-features are highlighted by black squares. (ii) Database of 
convergent immune repertoire sequences. (iii) K-mer sequence decomposition and 
classification of immune repertoire sequences. 
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Figure 2 An overview of selected computational tools used in immune repertoire 
analyses. Each colored bar in the Basis column represents a unique antibody or TCR 
sequence. Red bars across represent sequence differences or somatic hypermutation. The 
Method column describes the general concept of the computational methods and how these 
are applied to immune repertoires. The Tools column highlights exemplary key resources 
for performing computational analysis in the respective analytical sections (rows, A–D).  
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